Vaccinations in Children Treated with Standard-Dose Cancer Therapy or Hematopoietic Stem Cell Transplantation

Pediatric Clinics of North America

Volumn 55, Issue 1, 2008, Pages 169-186

  Patel, Soonie R ^a   Chisholm, Julia C ^b   Heath, Paul T ^c  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALTEPLASE; ANTINEOPLASTIC AGENT; BCG VACCINE; CHICKENPOX VACCINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PENICILLIN G; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; PURINE NUCLEOSIDE DERIVATIVE; STEROID; TETANUS TOXOID; VACCINE; VINCRISTINE; YELLOW FEVER VACCINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN ANTIBODY COMPLEX; BACTERIAL INFECTION; CANCER IMMUNOTHERAPY; CANCER THERAPY; CHICKENPOX; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HAEMOPHILUS INFLUENZAE TYPE B; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOMA; NEPHROBLASTOMA; RASH; REVIEW; RISK ASSESSMENT; VACCINATION;

EID: 38649090062     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.10.012     Document Type: Review

References (84)

1. Feldman S., Gigliotti F., Shenep J.L., et al. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 161 (1990) 926-931
2. Meisel R., Toschke M., Heiligensetzer C., et al. Increased risk for invasive pneumococcal disease in children with acute lymphoblastic leukaemia. Br J Haematol 137 (2007) 457-460
3. Kaplan L.J., Daum R.S., Smaron M., et al. Severe measles in immunocompromised patients. JAMA 267 (1992) 1237-1241
4. Feldman S., and Lott L. Varicella in children: impact of antiviral therapy and prophylaxis. Pediatrics 80 4 (1987) 465-472
5. Martin Ibáñez I., Arce Casas A., Cruz Martinez O., et al. Humoral immunity in pediatric patients with acute lymphoblastic leukaemia. Allergol Immunopathol (Madr) 31 (2003) 303-310
6. Ercan T.E., Soycan L.Y., Apak H., et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukaemia. J Pediatr Hematol Oncol 27 (2005) 273-277
7. Alanko S., Pelliniemi T.T., and Salmi T.T. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukaemia. Cancer 69 (1992) 1481-1486
8. Caver T.E., Slobod K.S., Flynn P.M., et al. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukaemia. Leukemia 12 (1998) 619-622
9. Alanko S., Salmi T.T., and Pelliniemi T.T. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukaemia. Pediatr Hematol Oncol 11 (1994) 281-292
10. Abrahamsson J., Marky I., and Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up. Acta Paediatr 84 (1995) 177-182
11. Kristinsson V.H., Kristinsson J.R., Jonmundsson G.K., et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukaemia. Pediatr Hematol Oncol 18 (2001) 167-172
12. Nilsson A., De Milito A., Engström P., et al. Current chemotherapy protocols for childhood acute lymphoblastic leukaemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 109 (2002) 1-6
13. Zignol M., Peracchi M., Tridello G., et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 101 (2004) 635-641
14. Ek T., Mellander L., Hahn-Zoric M., et al. Intensive treatment for childhood acute lymphoblastic leukaemia reduces immune responses to diphtheria, tetanus and Haemophilus influenzae type b. J Pediatr Hematol Oncol 26 (2004) 727-734
15. Fioredda F., Plebani A., Hanau G., et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible stratergy. Eur J Haematol 74 (2005) 20-23
16. Ridgway D., Wolff L.J., and Deforest A. Immunisation response varies with intensity of acute lymphoblastic leukaemia therapy. Am J Dis Child 145 (1991) 887-891
17. Feldman S., Andrew M., Norris B., et al. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunised children treated for acute leukaemia. Clin Infect Dis 27 (1998) 388-390
18. Patel S.R., Ortin M., Cohen B., et al. Re-immunization of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 44 5 (2007) 635-642
19. von der Hardt K., Jungert J., Beck J.D., et al. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents-a retrospective analysis. Vaccine 18 (2000) 2999-3004
20. Leung T.F., Li C.K., Hung E.C., et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 72 5 (2004) 353-357
21. Gershon A.A., and Steinberg S.P. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 320 14 (1989) 892-897
22. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 120 1 (2007) 221-231
23. Royal College of Paediatrics and Child Health. Immunisation of the immunocompromised child, best practice statement (2002), Royal College of Paediatrics and Child Health, United Kingdom
24. Chisholm J.C., Devine T., Charlett A., et al. Response to influenza immunisation during treatment for cancer. Arch Dis Child 84 (2001) 496-500
25. Smith S., Schiffman G., Karayalcin G., et al. Immunodeficiency in long-term survivors of acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster therapy. J Pediatr 127 (1995) 68-75
26. American Academy of Pediatrics Committee on Infectious Diseases. Red book, Section 1, Immunization of immunocompromised children (2006), American Academy of Pediatrics, Elk Grove Village (IL)
27. Krivit W. Overwhelming postsplenectomy infection. Am J Hematol 2 (1977) 193-201
28. Woolfrey A.E., Anasetti C., Storer B., et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukaemia in children. Blood 99 (2002) 2002-2008
29. Knecht H., Jost R., Gmur J., et al. Functional hyposplenia after allogeneic bone marrow transplantation is detected by epinephrine stimulation test and splenic ultrasonography. Eur J Haematol 41 (1988) 382-387
30. Adkins B., Gandour D., Strober S., et al. Total irradiation leads to transient depletion of the mouse thymic medulla and persistent abnormalities among medullary stromal cells. J Immunol 140 (1988) 3373-3379
31. Lum L.G., Seigneuret M.C., Storb R.F., et al. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 58 (1981) 431-439
32. Fallen P.R., McGreavey L., Madrigal J.A., et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 32 (2003) 1001-1014
33. Lum L.G. The kinetics of immune reconstitution after human marrow transplantation. Blood 69 (1987) 369-380
34. Ueda M., Harada M., Shiobara S., et al. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. Transplantation 37 (1984) 552-556
35. Foot A.B., Potter M.N., Donaldson C., et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 11 1 (1993) 7-13
36. de Vries E., Van Tol M.J.D., Langlois van den Bergh R., et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant 25 (2000) 267-275
37. Steingrimsdottir H., Gruber A., Bjorkholm M., et al. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high dose therapy and infectious complications. Haematologica 85 (2000) 832-838
38. Chakraverty R., Robinson S., Peggs K., et al. Excessive T-cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation. Bone Marrow Transplant 2899 (2001) 827-834
39. Kalwak K., Gorcynska E., Toporski J., et al. Immune reconstitution after haematopoietic stem cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 118 (2002) 74-89
40. Hammarström V., Pauksen K., Svensson H., et al. Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients. Transplantation 69 (2000) 1582-1586
41. Lum L.G., Munn N.A., Schanfield M.S., et al. The detection of specific antibody formation to recall antigens after human marrow transplantation. Blood 67 (1986) 582-587
42. Hochberg E.P., Chillemi A.C., Wu C.J., et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 98 (2001) 1116-1121
43. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332 (1995) 143-149
44. Storek J., Joseph A., Dawson M.A., et al. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 73 (2002) 1154-1158
45. Ljungman P., Cordonnier C., de Bock R., et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 15 (1995) 455-460
46. Henning K.J., White M.H., Sepkowitz K.A., et al. A national survey of immunisation practices following allogeneic bone marrow transplantation. JAMA 277 (1997) 1148-1151
47. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of CDC, Infectious society of America and the American society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 49 RR-10 (2000) 1-125
48. Ljungman P., Engelhard D., Cámara R de la, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 35 (2005) 737-746
49. Engelhard D., Nagler A., Hardan I., et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell-depleted and autologous BMT recipients. Bone Marrow Transplant 11 1 (1993) 1-5
50. Avanzini M.A., Carra A.M., Maccario R., et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 15 (1995) 137-144
51. Parkkali T., Olander R.-M., Ruutu T., et al. A randomised comparison between early and late vaccination with tetanus toxoid vaccine in allogeneic BMT. Bone Marrow Transplant 19 (1997) 933-938
52. Parkkali T., Stenvik M., Ruutu T., et al. Randomised comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 20 (1997) 663-668
53. Ljungman P., Wiklund-Hammarsten M., Duraj V., et al. Response to tetanus toxoid immunisation after allogeneic bone marrow transplantation. J Infect Dis 162 (1990) 496-500
54. Ljungman P., Duraj V., and Magnius L. Response to immunisation against polio after allogeneic marrow transplantation. Bone Marrow Transplant 7 2 (1991) 89-93
55. Guinan E.C., Molrine D.C., Antin J.H., et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57 (1994) 677-684
56. Spoulou V., Giannaki M., Vounatsou M., et al. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplant 33 (2004) 1187-1190
57. Ljungman P., Aschan J., Gustafsson B., et al. Long-term immunity to poliovirus after vaccination of allogeneic stem cell recipients. Bone Marrow Transplant 34 (2004) 1067-1069
58. Ljungman P., Fridell E., Lonnqvist B., et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps and rubella vaccine. J Infect Dis 159 (1989) 610-615
59. Patel S.R., Ortín M., Cohen B.J., et al. Re-immunization with Measles, Tetanus, Poliovirus, Haemophilus influenzae type b, Meningococcus C and Pneumococcal vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis 44 5 (2007) 625-634
60. Ljungman P., Aschan J., Barkholt L., et al. Measles immunity after allogeneic stem cell transplantation; influence of donor-type, graft type, intensity of conditioning and GvHD. Bone Marrow Transplant 34 (2004) 589-593
61. Ljungman P., Lewensohn-Fuchs I., Hammarstrom V., et al. Long-term immunity to measles, mumps and rubella after allogeneic bone marrow transplantation. Blood 84 (1994) 657-663
62. Molrine D.C., Antin J.H., Guinan E.C., et al. Donor immunisation with pneumococcal conjugate vaccine allows early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101 (2003) 831-836
63. Storek J., Dawson M.A., Lim L.C.-L., et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination before and early after transplantation. Bone Marrow Transplant 33 (2004) 337-346
64. Parkkali T., Käyhty H., Hovi T., et al. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplant 39 3 (2007) 179-188
65. Vance E., George S., Guinan E.C., et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 22 (1998) 735-741
66. Parkkali T., Ruutu T., Stenvik M., et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 104 (1996) 383-388
67. Florax A., Ehlert K., Becker K., et al. Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination?. Bone Marrow Transplant 38 9 (2006) 639-640
68. Engelhard D., Handsher R., Naparstek E., et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 8 (1991) 295-300
69. King S.M., Saunders E.F., Petric M., et al. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 17 (1996) 633-636
70. Machado C.M., Gonçalves F.B., Pannuti C.S., et al. Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. Blood 99 (2002) 83-87
71. Machado C.M., de Souza V.A., Sumita L.M., et al. Early measles vaccination in bone marrow transplant recipients. Bone Marrow Transplant 35 (2005) 787-791
72. Pauksen K., Duraj V., Ljungman P., et al. Immunity to and immunisation against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 9 (1992) 427-432
73. Machado C.M., Cardoso M.R., da Rocha I.F., et al. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 36 10 (2005) 897-900
74. Winston D.J., Schiffman G., Wang D., et al. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 91 (1979) 835-841
75. Kulkarni S., Powles R., Treleaven J., et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 95 (2000) 3683-3686
76. Reacher M.H., Shah A., Livermore D.M., et al. Bacteraemia and antibiotic resistance of its pathogens in England and Wales between 1990 and 1998: trend analysis. BMJ 320 (2000) 213-216
77. Spoulou V., Victoratos P., Ioannidis J.P.A., et al. Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. J Infect Dis 182 (2000) 965-969
78. Barra A., Cordonnier C., Preziosi M.P., et al. Immunogenecity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 166 (1992) 1021-1028
79. Avanzini M.A., Carra A.M., Maccario R., et al. Immunisation with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy matched controls. J Clin Immunol 18 (1998) 193-201
80. Schutze G.E., Mason E.O., Wald E.R., et al. Pneumococcal infections in children after transplantation. Clin Infect Dis 33 (2001) 16-21
81. Engelhard D., Cordonnier C., Shaw P.J., et al. Infectious Disease Working Party of the European Bone Marrow Transplantation; early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplant survey. Br J Haematol 117 (2002) 444-450
82. Sheridan J.F., Tutschka P.J., Sedmak D.D., et al. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 75 (1990) 1583-1586
83. Winston D.J., Ho W.G., Schiffman G., et al. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 143 (1983) 1735-1737
84. Meisel R., Kuypers L., Dirksen U., et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 109 6 (2007) 2322-2326